Cause of death, by non-communicable diseases, ages 5-14, female in France
France: Cause of death, by non-communicable diseases, ages 5-14, female was 66.8% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in France, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
France recorded 66.8% for cause of death, by non-communicable diseases, ages 5-14, female in 2021.
That represents a change of up 0.9% on the previous year and down 2.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in France peaked at 68.7% in 2010 and was at its lowest, 57.7%, in 2000.
That places France 22nd out of 184 countries with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 5-14, female in France, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 57.7% | — |
| 2010 | 68.7% | +19.1% |
| 2015 | 64.3% | -6.5% |
| 2019 | 64.7% | +0.7% |
| 2020 | 66.2% | +2.3% |
| 2021 | 66.8% | +0.9% |
France compared with similar countries
- France's 66.8% is above the median for high income countries, which is 61.7%, 1.1× the median. (57 countries reporting)
- France's 66.8% is above the median for Europe & Central Asia, which is 60.6%, 1.1× the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 57.7% | 57.7% | 57.7% | 1 |
| 2010s | 65.9% | 64.3% | 68.7% | 3 |
| 2020s | 66.5% | 66.2% | 66.8% | 2 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.7875 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0244 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8291 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in France?
- Cause of death, by non-communicable diseases, ages 5-14, female in France was 66.8% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in France?
- The highest recorded value was 68.7% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in France?
- The lowest recorded value was 57.7% in 2000.
- How does France rank for cause of death, by non-communicable diseases, ages 5-14, female?
- France ranks 22nd out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in France?
- Over the last ten years it is down 2.8%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.